The crossroad of RAAS modulation, inflammation, and oxidative stress in dialysis patients: light at the end of the tunnel?

J Am Soc Nephrol. 2012 Feb;23(2):189-91. doi: 10.1681/ASN.2011121208. Epub 2012 Jan 12.
No abstract available

Publication types

  • Editorial
  • Research Support, N.I.H., Extramural
  • Comment

MeSH terms

  • Angiotensin Receptor Antagonists / therapeutic use*
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use*
  • Female
  • Humans
  • Inflammation / prevention & control*
  • Male
  • Ramipril / therapeutic use*
  • Renal Dialysis / adverse effects*
  • Tetrazoles / therapeutic use*
  • Valine / analogs & derivatives*
  • Valine / therapeutic use
  • Valsartan

Substances

  • Angiotensin Receptor Antagonists
  • Angiotensin-Converting Enzyme Inhibitors
  • Tetrazoles
  • Valsartan
  • Valine
  • Ramipril